{
  "model": "google/medgemma-4b-it",
  "dataset": "MedQA",
  "method": "rag",
  "use_vllm": true,
  "corpus": "Textbooks",
  "retriever": "MedCPT",
  "total_questions": 3,
  "correct_answers": 2,
  "accuracy": 66.66666666666666,
  "total_time_minutes": 0.301598068078359,
  "avg_time_per_question": 6.03196136156718,
  "results": [
    {
      "question_id": 0,
      "question": "A junior orthopaedic surgery resident is completing a carpal tunnel repair with the department chairman as the attending physician. During the case, the resident inadvertently cuts a flexor tendon. The tendon is repaired without complication. The attending tells the resident that the patient will do fine, and there is no need to report this minor complication that will not harm the patient, as he does not want to make the patient worry unnecessarily. He tells the resident to leave this complication out of the operative report. Which of the following is the correct next action for the resident to take?",
      "options": {
        "A": "Disclose the error to the patient and put it in the operative report",
        "B": "Tell the attending that he cannot fail to disclose this mistake",
        "C": "Report the physician to the ethics committee",
        "D": "Refuse to dictate the operative report"
      },
      "correct_answer": "B",
      "predicted_answer": "A",
      "is_correct": false,
      "raw_answer": "```json { \"step_by_step_thinking\": \"The resident is in a situation where the attending physician is instructing the resident to conceal a surgical error (cutting a flexor tendon). This is a violation of ethical principles and potentially legal requirements. The resident has a duty to report the error, even if it seems minor. The attending's instruction to omit the error from the operative report is unethical and potentially illegal. The resident should not be pressured into concealing the error. The resident should report the error to the appropriate authority, which could be the attending, the hospital ethics committee, or a regulatory body. The resident should not refuse to dictate the operative report, as that would be a direct violation of the attending's instructions and potentially a cover-up of a medical error. The resident should disclose the error to the patient, as the patient has a right to know about any complications or errors that occurred during their surgery. The resident should put the error in the operative report, as this is the standard procedure for documenting surgical events. Therefore, the correct course of action is to disclose the error to the patient and put it in the operative report.\", \"answer_choice\": \"A\" } ```",
      "num_snippets": 32,
      "rag_snippets": [
        {
          "id": "Surgery_Schwartz_2776",
          "title": "Surgery_Schwartz",
          "content": "wrong-site operations, orthopedic surgeons may be more likely to report these events when they do occur.47The Joint Commission Universal Protocol to Ensure Correct SurgeryThe movement to eliminate wrong-site surgery began among professional orthopedic societies in the mid-1990s, when both the Canadian Orthopaedic Association and the American Acad-emy of Orthopaedic Surgeons issued position statements and embarked on educational campaigns to prevent the occurrence of wrong-site surgery within their specialty.47 Other organiza-tions that issued position statements advocating for the elimina-tion of wrong-site surgery include the North American Spine Society, the American Academy of Ophthalmology, the Asso-ciation of Perioperative Registered Nurses, and the American College of Surgeons. After issuing a review of wrong-site sur-gery in their Sentinel Event Alert in 1998, The Joint Commis-sion made the elimination of wrong-site surgery one of their first National Patient Safety Goals in"
        },
        {
          "id": "Surgery_Schwartz_2775",
          "title": "Surgery_Schwartz",
          "content": "error sometime during their careers.47 The specialties most com-monly involved in reporting wrong-site surgeries according to The Joint Commission are orthopedic/podiatric surgery (41%); general surgery (20%); neurosurgery (14%); urology (11%); and maxillofacial, cardiovascular, otolaryngology, and oph-thalmology (14%).46 Most errors involved symmetric anatomic structures: lower extremities (30%), head/neck (24%), and geni-tal/urinary/pelvic/groin (21%).42 Although orthopedic surgery is the most frequently involved, this may be due to the higher volume of cases performed as well as the increased opportu-nity for lateralization errors inherent in the specialty. In addi-tion, because the American Academy of Orthopaedic Surgeons has historically tried as a professional organization to reduce wrong-site operations, orthopedic surgeons may be more likely to report these events when they do occur.47The Joint Commission Universal Protocol to Ensure Correct SurgeryThe movement to eliminate"
        },
        {
          "id": "Surgery_Schwartz_3241",
          "title": "Surgery_Schwartz",
          "content": "one or several surgical teams were able to perform an operation does not ensure that all others with the same medical degrees can perform the operation with equal skill. It behooves the learners to contact the experts and request their assistance to ensure an optimal outcome at the new center. Although it is important that the learners contact the experts, it is equally important that the experts be willing to share their experience with their fellow professionals. As well, the experts should provide feedback to the learners as to whether they feel the learners are equipped to forge ahead on their own. If not, further observation and assistance from the experts are required. Although this approach may sound obvious, it is fraught with difficulties. In many situations, ego, competitiveness, and mon-etary concerns have short-circuited this process and led to poor patient outcomes. To a large extent, MIS has recovered from the black eye it received early in development, when inadequately"
        },
        {
          "id": "Surgery_Schwartz_2791",
          "title": "Surgery_Schwartz",
          "content": "been linked to lack of surgeon specialization, low hospital volume, communication breakdowns, fatigue, surgical residents and trainees, and numer-ous other factors.53However, poor surgical outcomes are not necessarily cor-related with a surgeon\u2019s level of experience in performing a cer-tain procedure. In one study, three-fourths of the technical errors that occurred in a review of malpractice claims data involved fully trained and experienced surgeons operating within their area of expertise, and 84% occurred in routine operations that do not require advanced training. Rather than surgeon expertise, these errors likely occurred due to situations complicated by patient comorbidity, complex anatomy, repeat surgery, or equip-ment problems (Table 12-11). Because these errors occurred during routine operations, previous suggestions to limit the per-formance of high-complexity operations using selective refer-ral, regionalization, or limitation of privileging may not actually be effective"
        },
        {
          "id": "Surgery_Schwartz_2761",
          "title": "Surgery_Schwartz",
          "content": "who were named in a surgical never event claim, 12.4% were named in a future never events claim.41 Another study in 2010 by The Joint Commission found that wrong-site surgery occurs 40 times per week nationwide.42 Future directions for decreasing these prob-lems include public reporting of never events by hospitals to increase hospital accountability, more formal training in team-work, and CUSP programs in hospitals that have higher rates of never events to help elucidate the root cause.Retained Surgical ItemsA retained surgical item refers to any surgical item found to be inside a patient after he or she has left the OR, thus requiring a second operation to remove the item.43 Estimates of retained for-eign bodies in surgical procedures range from one case per 8000 to 18,000 operations, corresponding to one case or more each year for a typical large hospital or approximately 1500 cases per year in the United States.44 This estimate is based on an analy-sis of malpractice claims and is"
        }
      ],
      "rag_scores": [
        62.69739532470703,
        62.370948791503906,
        62.33161163330078,
        62.167484283447266,
        62.147247314453125
      ],
      "actual_prompt": "Question: A junior orthopaedic surgery resident is completing a carpal tunnel repair with the department chairman as the attending physician. During the case, the resident inadvertently cuts a flexor tendon. The tendon is repaired without complication. The attending tells the resident that the patient will do fine, and there is no need to report this minor complication that will not harm the patient, as he does not want to make the patient worry unnecessarily. He tells the resident to leave this complication out of the operative report. Which of the following is the correct next action for the resident to take?\nOptions: {'A': 'Disclose the error to the patient and put it in the operative report', 'B': 'Tell the attending that he cannot fail to disclose this mistake', 'C': 'Report the physician to the ethics committee', 'D': 'Refuse to dictate the operative report'}\nRAG Context: Retrieved 32 snippets",
      "rag_analysis": {
        "total_retrieved": 32,
        "top_snippet_length": 3,
        "avg_snippet_length": 3.0,
        "score_range": [
          62.147247314453125,
          62.69739532470703
        ]
      }
    },
    {
      "question_id": 1,
      "question": "A 67-year-old man with transitional cell carcinoma of the bladder comes to the physician because of a 2-day history of ringing sensation in his ear. He received this first course of neoadjuvant chemotherapy 1 week ago. Pure tone audiometry shows a sensorineural hearing loss of 45 dB. The expected beneficial effect of the drug that caused this patient's symptoms is most likely due to which of the following actions?",
      "options": {
        "A": "Inhibition of proteasome",
        "B": "Hyperstabilization of microtubules",
        "C": "Generation of free radicals",
        "D": "Cross-linking of DNA"
      },
      "correct_answer": "D",
      "predicted_answer": "D",
      "is_correct": true,
      "raw_answer": "Here's a step-by-step breakdown of the question and the reasoning for the answer: 1. **Identify the Patient's Condition:** The patient has a history of bladder cancer and is undergoing neoadjuvant chemotherapy. He is experiencing sensorineural hearing loss. 2. **Consider the Chemotherapy Regimen:** The question implies that the chemotherapy regimen is likely cisplatin-based, given the patient's age and the fact that cisplatin is a common treatment for bladder cancer. 3. **Recall the Mechanism of Action of Cisplatin:** Cisplatin is a platinum-based chemotherapy drug. Its primary mechanism of action involves the formation of DNA adducts, leading to DNA damage and cell death. 4. **Relate the Mechanism of Action to the Symptom:** The sensorineural hearing loss is likely due to ototoxicity, a known side effect of cisplatin. Ototoxicity results from the drug's interaction with DNA and RNA, leading to damage to the hair cells in the inner ear. 5. **Evaluate the Answer Choices:** * A. Inhibition of proteasome: This is the mechanism of action of proteasome inhibitors like bortezomib, which are used in multiple myeloma and lymphoma, not typically cisplatin. * B. Hyperstabilization of microtubules: This is the mechanism of action of taxanes like paclitaxel, which are used in breast cancer, ovarian cancer, and lung cancer, not typically cisplatin. * C. Generation of free radicals: While some chemotherapy drugs generate free radicals, this is not the primary mechanism of cisplatin. * D. Cross-linking of DNA: This is the primary mechanism of action of cisplatin. Cisplatin forms DNA adducts, leading to DNA damage and cell death. 6. **Conclusion:** The most likely mechanism of action of cisplatin, given the patient's symptoms, is the cross-linking of DNA. ```json { \"step_by_step_thinking\": \"The patient is undergoing neoadjuvant chemotherapy for bladder cancer and is experiencing sensorineural hearing loss, likely due to cisplatin. Cisplatin's primary mechanism of action is the formation of DNA adducts, leading to DNA damage and cell death. Therefore, the expected beneficial effect of the drug is due to cross-linking of DNA.\", \"answer_choice\": \"D\" } ```",
      "num_snippets": 32,
      "rag_snippets": [
        {
          "id": "InternalMed_Harrison_6781",
          "title": "InternalMed_Harrison",
          "content": "As with any treatment recommendation, the risks and benefits of adjuvant chemotherapy should be considered on an individual patient basis. If a decision is made to proceed with adjuvant chemotherapy, in general, treatment should be initiated 6\u201312 weeks after surgery, assuming the patient has fully recovered, and should be administered for no more than four cycles. Although a cisplatinbased chemotherapy is the preferred treatment regimen, carboplatin can be substituted for cisplatin in patients who are unlikely to tolerate cisplatin for reasons such as reduced renal function, presence of neuropathy, or hearing impairment. No specific chemotherapy regimen is considered optimal in this setting, although platinum plus vinorelbine is most commonly used."
        },
        {
          "id": "Neurology_Adams_2288",
          "title": "Neurology_Adams",
          "content": "This has many causes. The common high-frequency sensorineural type of hearing loss in the aged (presbycusis) is probably a result of neuronal degeneration, that is, progressive loss of spiral ganglion neurons (Suga and Lindsay). Explosions or intense, sustained noise in certain industrial settings or from gun blasts or even rock music may result in a high-tone sensorineural hearing loss from cochlear damage. Certain antimicrobial drugs (namely, the aminoglycoside group and vancomycin) damage cochlear hair cells and, after prolonged use, can result in severe hearing loss. If these drugs have been used to treat bacterial meningitis, it may be difficult to determine whether the antibiotic or the infection is the cause. A variety of other commonly used drugs are ototoxic, including certain neurotoxic cancer chemotherapies, especially platinum containing drugs, usually in a dose-dependent fashion (see Nadol). Quinine and acetylsalicylic acid may impair sensorineural function transiently."
        },
        {
          "id": "InternalMed_Harrison_7928",
          "title": "InternalMed_Harrison",
          "content": "Vinca alkaloids produce a characteristic \u201cstocking-glove\u201d neuropathy with numbness and tingling advancing to loss of motor function, which is highly dose related. Distal sensorimotor polyneuropathy prominently involves loss of deep tendon reflexes with initially loss of pain and temperature sensation, followed by proprioceptive and vibratory loss. This requires careful patient history and physical examination by experienced oncologists to decide when the drug must be stopped due to toxicity. Milder toxicity often slowly completely resolves. Vinca alkaloids may sometimes be associated with jaw claudication, autonomic neuropathy, ileus, cranial nerve palsies, and, in severe cases, encephalopathy, seizures, and coma. Cisplatin is associated with sensorimotor neuropathy and hearing loss, especially at doses >400 mg/m2, requiring audiometry in patients with preexisting hearing compromise. Carboplatin is often substituted in such cases given its lesser effect on hearing."
        },
        {
          "id": "InternalMed_Harrison_10281",
          "title": "InternalMed_Harrison",
          "content": "(or vestibular toxicity with streptomycin) is not uncommon during treatment lasting 4\u20136 weeks. Regimens in which the aminoglycoside component is given for only 2\u20133 weeks have been curative and associated with less nephrotoxicity than those using longer courses of gentamicin. Thus regimens wherein gentamicin is administered for only 2\u20133 weeks are preferred by some."
        },
        {
          "id": "InternalMed_Harrison_7370",
          "title": "InternalMed_Harrison",
          "content": "A number of chemotherapeutic drugs have activity as single agents; cisplatin, paclitaxel, and gemcitabine are considered most active. Standard therapy consists of two-, three-, or four-drug combina tions. Overall response rates of >50% have been reported using combinations such as methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC); gemcitabine and cisplatin (GC); or gemcitabine, paclitaxel, and cisplatin (GPC). MVAC was considered standard, but the toxicities of neutropenia and fever, mucositis, diminished renal and auditory function, and peripheral neuropathy led to the development of alternative regimens. At present, GC is used more commonly than MVAC based on the results of a comparative trial of MVAC versus GC that showed less neutropenia and fever and less mucositis for the GC regimen with similar response rates and median overall survival. Anemia and thrombocytopenia were more common with GC. GPC is not more effective than GC."
        }
      ],
      "rag_scores": [
        63.83208465576172,
        62.409423828125,
        61.854736328125,
        61.81045150756836,
        61.593727111816406
      ],
      "actual_prompt": "Question: A 67-year-old man with transitional cell carcinoma of the bladder comes to the physician because of a 2-day history of ringing sensation in his ear. He received this first course of neoadjuvant chemotherapy 1 week ago. Pure tone audiometry shows a sensorineural hearing loss of 45 dB. The expected beneficial effect of the drug that caused this patient's symptoms is most likely due to which of the following actions?\nOptions: {'A': 'Inhibition of proteasome', 'B': 'Hyperstabilization of microtubules', 'C': 'Generation of free radicals', 'D': 'Cross-linking of DNA'}\nRAG Context: Retrieved 32 snippets",
      "rag_analysis": {
        "total_retrieved": 32,
        "top_snippet_length": 3,
        "avg_snippet_length": 3.0,
        "score_range": [
          61.593727111816406,
          63.83208465576172
        ]
      }
    },
    {
      "question_id": 2,
      "question": "Two weeks after undergoing an emergency cardiac catherization with stenting for unstable angina pectoris, a 61-year-old man has decreased urinary output and malaise. He has type 2 diabetes mellitus and osteoarthritis of the hips. Prior to admission, his medications were insulin and naproxen. He was also started on aspirin, clopidogrel, and metoprolol after the coronary intervention. His temperature is 38\u00b0C (100.4\u00b0F), pulse is 93/min, and blood pressure is 125/85 mm Hg. Examination shows mottled, reticulated purplish discoloration of the feet. Laboratory studies show:\nHemoglobin count 14 g/dL\nLeukocyte count 16,400/mm3\nSegmented neutrophils 56%\nEosinophils 11%\nLymphocytes 31%\nMonocytes 2%\nPlatelet count 260,000/mm3\nErythrocyte sedimentation rate 68 mm/h\nSerum\nUrea nitrogen 25 mg/dL\nCreatinine 4.2 mg/dL\nRenal biopsy shows intravascular spindle-shaped vacuoles. Which of the following is the most likely cause of this patient's symptoms?\"",
      "options": {
        "A": "Renal papillary necrosis",
        "B": "Cholesterol embolization",
        "C": "Eosinophilic granulomatosis with polyangiitis",
        "D": "Polyarteritis nodosa"
      },
      "correct_answer": "B",
      "predicted_answer": "B",
      "is_correct": true,
      "raw_answer": "Here's a step-by-step analysis to determine the most likely cause of the patient's symptoms: 1. **Patient Presentation:** The patient presents with fever, malaise, decreased urinary output, mottled purplish discoloration of the feet, elevated ESR, and renal insufficiency. He has a history of diabetes, recent cardiac catherization with stenting, and is on aspirin and clopidogrel. 2. **Differential Diagnosis:** The combination of symptoms and risk factors points towards several possibilities, including: * **Renal papillary necrosis:** This can occur with prolonged use of NSAIDs (naproxen), diabetes, and other conditions. * **Cholesterol embolization:** This can occur after vascular procedures, especially those involving the aorta or iliac arteries. * **Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome):** This is a rare vasculitis that can cause renal involvement, but it is less likely given the patient's history and the biopsy findings. * **Polyarteritis nodosa (PAN):** This is a systemic vasculitis that can affect multiple organs, including the kidneys and skin. 3. **Key Findings and Reasoning:** * **Recent cardiac catherization with stenting:** This increases the risk of cholesterol embolization. * **NSAID use (naproxen):** This increases the risk of renal papillary necrosis. * **Diabetes:** This increases the risk of renal papillary necrosis. * **Mottled purplish discoloration of the feet:** This is a classic sign of cholesterol embolization. * **Elevated ESR:** This is a non-specific finding that can be seen in many inflammatory conditions. * **Renal insufficiency:** This can be caused by various conditions, including renal papillary necrosis, cholesterol embolization, and vasculitis. * **Renal biopsy showing intravascular spindle-shaped vacuoles:** This is highly suggestive of cholesterol embolization. 4. **Conclusion:** Given the patient's recent cardiac catherization, the presence of mottled purplish discoloration of the feet, and the renal biopsy findings, cholesterol embolization is the most likely diagnosis. ```json { \"step_by_step_thinking\": \"The patient presents with symptoms suggestive of a vascular issue, particularly after a recent cardiac procedure. The mottled purplish discoloration of the feet is a key indicator of cholesterol embolization. The renal biopsy showing intravascular spindle-shaped vacuoles further supports this diagnosis. While other conditions are possible, the combination of factors points most strongly to cholesterol embolization. Therefore, the answer is B.\", \"answer_choice\": \"B\" } ```",
      "num_snippets": 32,
      "rag_snippets": [
        {
          "id": "First_Aid_Step1_803",
          "title": "First_Aid_Step1",
          "content": "Chest pain with ST depressions on ECG Angina (\u229d troponins) or NSTEMI (\u2295 troponins) 307 fever following MI fibrinous pericarditis, 2 weeks to several months after acute episode) Painful, raised red lesions on pads of fingers/toes Osler nodes (infective endocarditis, immune complex Painless erythematous lesions on palms and soles Janeway lesions (infective endocarditis, septic emboli/ 311 microabscesses) Retinal hemorrhages with pale centers Roth spots (bacterial endocarditis) Distant heart sounds, distended neck veins, hypotension Beck triad of cardiac tamponade Cervical lymphadenopathy, desquamating rash, coronary Kawasaki disease (mucocutaneous lymph node syndrome, 314 aneurysms, red conjunctivae and tongue, hand-foot treat with IVIG and aspirin) changes Palpable purpura on buttocks/legs, joint pain, abdominal Immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein 315 pain (child), hematuria purpura, affects skin and kidneys)"
        },
        {
          "id": "InternalMed_Harrison_18845",
          "title": "InternalMed_Harrison",
          "content": "There is no specific therapy for acute idiopathic pericarditis, but bed rest and anti-inflammatory treatment with aspirin (2\u20134 g/d), with gastric protection (e.g., omeprazole 20 mg/d), may be given. If this is ineffective, one of the nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (400\u2013600 mg tid) or indomethacin (25\u201350 mg tid), should be tried. In responsive patients, these doses should be continued for 1\u20132 weeks and then tapered over several weeks. In patients who are unresponsive, colchicine (0.5 mg bid, given for 4\u20138 weeks) has been found to be effective, not only in acute pericarditis, but also in reducing the risk of recurrent pericarditis. Colchicine is concentrated in and interferes with the migration of neutrophils, is contraindicated in patients with hepatic or renal dysfunction, and may cause diarrhea and other gastrointestinal side effects. Glucocorticoids (e.g., prednisone 1 mg/kg per day) usually suppress the clinical manifestations of acute pericarditis"
        },
        {
          "id": "InternalMed_Harrison_19090",
          "title": "InternalMed_Harrison",
          "content": "Although the diagnosis of IHD can be made with a high degree of confidence from the history and physical examination, a number of simple laboratory tests can be helpful. The urine should be examined for evidence of diabetes mellitus and renal disease (including microalbuminuria) since these conditions accelerate atherosclerosis. Similarly, examination of the blood should include measurements of lipids (cholesterol\u2014total, LDL, HDL\u2014and triglycerides), glucose (hemoglobin ), creatinine, hematocrit, and, if indicated based on the physical examination, thyroid function. A chest x-ray is important as it may show the consequences of IHD, i.e., cardiac enlargement, ventricular aneurysm, or signs of heart failure. These signs can support the diagnosis of IHD and are important in assessing the degree of cardiac damage. Evidence exists that an elevated level of high-sensitivity C-reactive protein (CRP) (specifically, between 0 and 3 mg/dL) is an independent risk factor for IHD and may be useful"
        },
        {
          "id": "InternalMed_Harrison_19215",
          "title": "InternalMed_Harrison",
          "content": "Excessive bleeding is the most important adverse effect of necrosis becomes positive, or there is evidence of severe ischemia all antithrombotic agents, including both antiplatelet agents on a stress test. and anticoagulants. Therefore, attention must be directed to the doses of antithrombotic agents, accounting for body weight, creatinine clearance, and a previous history of excessive bleeding, as The time of hospital discharge is a \u201cteachable moment\u201d for the patient a means of reducing the risk of bleeding. Patients who have experi with NSTE-ACS, when the physician can review and optimize the enced a stroke are at higher risk of intracranial bleeding with potent medical regimen. Risk-factor modification is key, and the caregiver antiplatelet agents and combinations of antithrombotic drugs."
        },
        {
          "id": "InternalMed_Harrison_615",
          "title": "InternalMed_Harrison",
          "content": "Age, weight, height 2. Are you: Female and 55 years of age or older or male and 45 years of age of older? If yes, are you 70 years of age or older? 3. Do you take anticoagulant medications (\u201cblood thinners\u201d)? 4. Do you have or have you had any of the following heart-related conditions? Heart disease Heart attack within the last 6 months Angina (chest pain) 5. Do you have or have you ever had any of the following? Rheumatoid arthritis Kidney disease Liver disease Diabetes 6. Do you get short of breath when you lie flat? 7. Are you currently on oxygen treatment? 8. Do you have a chronic cough that produces any discharge or fluid? 9. Do you have lung problems or diseases? 10. Have you or any blood member of your family ever had a problem other than nausea with any anesthesia? If yes, describe: 11."
        }
      ],
      "rag_scores": [
        62.300960540771484,
        61.9749755859375,
        61.94810104370117,
        61.86272048950195,
        61.784236907958984
      ],
      "actual_prompt": "Question: Two weeks after undergoing an emergency cardiac catherization with stenting for unstable angina pectoris, a 61-year-old man has decreased urinary output and malaise. He has type 2 diabetes mellitus and osteoarthritis of the hips. Prior to admission, his medications were insulin and naproxen. He was also started on aspirin, clopidogrel, and metoprolol after the coronary intervention. His temperature is 38\u00b0C (100.4\u00b0F), pulse is 93/min, and blood pressure is 125/85 mm Hg. Examination shows mottled, reticulated purplish discoloration of the feet. Laboratory studies show:\nHemoglobin count 14 g/dL\nLeukocyte count 16,400/mm3\nSegmented neutrophils 56%\nEosinophils 11%\nLymphocytes 31%\nMonocytes 2%\nPlatelet count 260,000/mm3\nErythrocyte sedimentation rate 68 mm/h\nSerum\nUrea nitrogen 25 mg/dL\nCreatinine 4.2 mg/dL\nRenal biopsy shows intravascular spindle-shaped vacuoles. Which of the following is the most likely cause of this patient's symptoms?\"\nOptions: {'A': 'Renal papillary necrosis', 'B': 'Cholesterol embolization', 'C': 'Eosinophilic granulomatosis with polyangiitis', 'D': 'Polyarteritis nodosa'}\nRAG Context: Retrieved 32 snippets",
      "rag_analysis": {
        "total_retrieved": 32,
        "top_snippet_length": 3,
        "avg_snippet_length": 3.0,
        "score_range": [
          61.784236907958984,
          62.300960540771484
        ]
      }
    }
  ]
}